Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series

por Giancarlo Fatobene, Gabriela Rodriguez de Souza, Celso Arrais Rodrigues, Yana Augusta Sarkis Novis, Vanderson Rocha
Publicado 2021

Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation

por Vinícius Campos de Molla, Vitor Heidrich, Julia Stephanie Bruno, Franciele Hinterholz Knebel, Wanessa Miranda-Silva, Paula Fontes Asprino, Luciana Tucunduva, Vanderson Rocha, Yana Novis, Anamaria Aranha Camargo, Eduardo Rodrigues Fregnani, Celso Arrais-Rodrigues
Publicado 2021

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphom...

por Alvaro J. Alencar, Alexandre V. Hirayama, Diego V. Clé, Marco Aurélio Salvino, Guilherme Perini, Celso Arrais, Otávio Baiocchi, Leonardo Carvalho Palma, Iago Colturato, Jorge Vaz, Ricardo Chiattone, Marcos de Lima, Jayr Schmidt Filho, Samir Nabhan, Vanderson Rocha, Renato L. Guerino-Cunha, Carlos S. Chiattone
Publicado 2021